HighMark Wealth Management’s Zymeworks ZYME Stock Holding History

HighMark Wealth Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2K	Sell	80 -150	-65%	-$3.55K	﹤0.01%	459
2025 Q4	$6.05K	Sell	230 -50	-18%	-$1.09K	﹤0.01%	379
2025 Q3	$4.78K	Hold	280	–	–	﹤0.01%	402
2025 Q2	$3.51K	Hold	280	–	–	﹤0.01%	440
2025 Q1	$3.33K	Hold	280	–	–	﹤0.01%	410
2024 Q4	$4.1K	Hold	280	–	–	﹤0.01%	396
2024 Q3	$3.51K	Hold	280	–	–	﹤0.01%	431
2024 Q2	$2.38K	Hold	280	–	–	﹤0.01%	455
2024 Q1	$2.95K	Hold	280	–	–	﹤0.01%	427
2023 Q4	$2.91K	Hold	280	–	–	﹤0.01%	433
2023 Q3	$1.77K	Hold	280	–	–	﹤0.01%	466
2023 Q2	$2.42K	Hold	280	–	–	﹤0.01%	438
2023 Q1	$2.53K	Hold	280	–	–	﹤0.01%	480
2022 Q4	$2.2K	Hold	280	–	–	﹤0.01%	424
2022 Q3	$2K	Hold	280	–	–	﹤0.01%	446
2022 Q2	$1K	Hold	280	–	–	﹤0.01%	501
2022 Q1	$2K	Hold	280	–	–	﹤0.01%	460
2021 Q4	$5K	Hold	280	–	–	﹤0.01%	373
2021 Q3	$8K	Buy	280 +50	+22%	+$1.66K	0.01%	292
2021 Q2	$8K	Sell	230 -19	-8%	-$603	0.01%	295
2021 Q1	$8K	Sell	249 -137	-35%	-$5.57K	0.01%	280
2020 Q4	$18K	Sell	386 -1,256	-76%	-$58.3K	0.02%	172
2020 Q3	$76K	Buy	1,642 +1,165	+244%	+$40K	0.07%	82
2020 Q2	$17K	Buy	+477	New	+$17.6K	0.02%	150

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HighMark Wealth Management's ZYME Position: Q1 2026 in Review

HighMark Wealth Management reduced its Zymeworks (ZYME) stake by 65% in Q1 2026, selling an estimated $3.55K and leaving 80 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #459.

HighMark Wealth Management first reported a position in ZYME in Q2 2020 and has held it in 24 quarters since. The position peaked at $76K in Q3 2020. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

HighMark Wealth Management held 80 shares of Zymeworks worth $2K as of Q1 2026.
HighMark Wealth Management sold 150 Zymeworks shares in Q1 2026, an estimated $3.55K.
Zymeworks made up ﹤0.01% of HighMark Wealth Management's portfolio in Q1 2026, its #459 holding.
HighMark Wealth Management first reported a position in Zymeworks in Q2 2020 and has held it in 24 quarters since.
HighMark Wealth Management's Zymeworks position peaked at $76K in Q3 2020.
211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on HighMark Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.